Blackstone Minerals Limited logo

Blackstone Minerals Limited (BSX)

Market Closed
CXA CXA
- Market Cap
74.55 P/E Ratio
0% Div Yield
23,944 Volume
2.01 Eps
Earnings results expected in 34 days

Summary

BSX closed today lower, a decrease of 3.33% from yesterday's close, completing a monthly increase of 12.99%. Over the past 12 months, BSX stock gained 171.87%.
BSX is not paying dividends to its shareholders.
The last earnings report, released on Apr 22, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.18%, based on the last three reports. The next scheduled earnings report is due on Jul 22, 2025.
The stock of the company had never split.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track BSX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
I'm Buying Dividend Aristocrats At Bargain Basement Prices

I'm Buying Dividend Aristocrats At Bargain Basement Prices

Now is an opportune time to focus on income stocks like that offer value and stability amid market volatility. I focus on 2 Dividend Aristocrats that are attractively valued while supporting well-covered dividends. Both carry A/A+ rated balance sheets and have potential for strong total returns with a solid starting yield.

Seekingalpha | 17 hours ago
What's Happening With Boston Scientific Stock?

What's Happening With Boston Scientific Stock?

Boston Scientific (NYSE:BSX) has experienced a stock price increase of over 30% in the last twelve months, greatly exceeding the S&P 500's gain of 9%. This remarkable performance can be credited to the launch of new products, which have enhanced sales growth and widened profit margins.

Forbes | 1 day ago
Why the Market Dipped But Boston Scientific (BSX) Gained Today

Why the Market Dipped But Boston Scientific (BSX) Gained Today

The latest trading day saw Boston Scientific (BSX) settling at $99.74, representing a +1.2% change from its previous close.

Zacks | 4 days ago

Blackstone Minerals Limited Dividends

BSX is not paying dividends to its shareholders.

Blackstone Minerals Limited Earnings

22 Jul 2025 (34 Days) Date
-
Cons. EPS
-
EPS
22 Apr 2025 Date
-
Cons. EPS
-
EPS
29 Jan 2025 Date
0.66
Cons. EPS
0.7
EPS
24 Oct 2024 Date
0.59
Cons. EPS
-
EPS
23 Oct 2024 Date
0.59
Cons. EPS
0.63
EPS
BSX is not paying dividends to its shareholders.
22 Jul 2025 (34 Days) Date
-
Cons. EPS
-
EPS
22 Apr 2025 Date
-
Cons. EPS
-
EPS
29 Jan 2025 Date
0.66
Cons. EPS
0.7
EPS
24 Oct 2024 Date
0.59
Cons. EPS
-
EPS
23 Oct 2024 Date
0.59
Cons. EPS
0.63
EPS

Blackstone Minerals Limited (BSX) FAQ

On which exchange is it traded?

Blackstone Minerals Limited is listed on NYSE.

What is its stock symbol?

The ticker symbol is BSX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Jul 22, 2025.

Has Blackstone Minerals Limited ever had a stock split?

Blackstone Minerals Limited had 0 splits and the recent split was on Nov 06, 2003.

Blackstone Minerals Limited Profile

Medical - Devices Industry
Healthcare Sector
Mr. Michael F. Mahoney CEO
CXA Exchange
US1011371077 ISIN
US Country
53,000 Employees
- Last Dividend
6 Nov 2003 Last Split
18 May 1992 IPO Date

Overview

Boston Scientific Corporation is a global developer, manufacturer, and marketer of medical devices used in a variety of interventional medical specialties. Having begun its operations in 1979, the company has grown to serve a diverse range of medical needs through its two primary segments: MedSurg and Cardiovascular. With its headquarters in Marlborough, Massachusetts, Boston Scientific is committed to improving patient health by providing cutting-edge solutions that address complex medical conditions and enhance the quality of life for patients worldwide.

Products and Services

  • Gastrointestinal and Pulmonary Devices: These include resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes. These devices are aimed at diagnosing and treating conditions within the gastrointestinal and pulmonary systems, offering advanced options for physicians and improved care for patients.
  • Urology Devices: Comprising ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincters, lasers, fibers, and hydrogel systems. These products target urological conditions, providing solutions that maintain urinary function and patient quality of life.
  • Neurology and Pain Management Devices: This category includes spinal cord stimulator systems, proprietary programming software, radiofrequency generators, indirect decompression systems, practice optimization tools, and deep brain stimulation systems. Designed for treating neurological movement disorders and chronic pain management, these devices help patients return to their normal activities with less discomfort.
  • Cardiovascular Technologies: Offering technologies for diagnosing and treating coronary artery disease and aortic valve conditions, including WATCHMAN FLX Left Atrial Appendage Closure Device. Boston Scientific focuses on delivering innovative solutions for heart diseases, aiming to improve patient outcomes and reduce healthcare costs.
  • Electrophysiology Devices: Including cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. These products are designed for the diagnosis and treatment of rate and rhythm disorders of the heart, enhancing life quality for patients with heart conditions.
  • Diseases of the Peripheral System: Devices targeting peripheral arterial and venous diseases, providing diagnostic and therapeutic options for patients suffering from these circulatory conditions.
  • Cancer Diagnosis and Treatment: Offering products that facilitate the diagnosis, treatment, and palliation of various forms of cancer, Boston Scientific aims to contribute to the overall cancer care continuum, from early detection to treatment and beyond.

Contact Information

Address: 300 Boston Scientific Way
Phone: 508 683 4000